Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration
PR Newswire•25/09/2026•18:02 ET
0
Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration PR Newswire
Kodiak Sciences to Host Webcast on Monday, September 28 at 8:30 AM Eastern Time
Get started
Create a free account to read the full story and Whiz Insights.